Search

everythinglearnresearchcommunity

for

Search:↓

Nonobese, normotensive Indian women with PCOS may have a higher risk of heart problems linked to inflammation and insulin resistance.

The gel made of minoxidil and hydroxypropyl-β-cyclodextrin improves hair growth and is good for long-term use.

Genetic testing for cancer risk can lead to early and life-saving treatments in people without symptoms.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

A woman with Budd-Chiari syndrome improved after treatment and needs a liver transplant, highlighting the importance of considering non-criteria antiphospholipid syndrome in similar cases.

Finasteride for hair loss may cause lasting sexual, genitourinary, mental, and anti-androgenic side effects in young men.

Fine needle aspiration with rapid on-site evaluation is useful for diagnosing pilomatrixoma.

Certain changes in the VEGF gene can increase or decrease the risk of polycystic ovary syndrome.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Cyclosporin extends hair growth in mice, but high-dose corticosteroids block this effect.

Chromium picolinate was better tolerated than metformin for PCOS with fewer side effects.

About 30% of women feel they lose too much hair, often starting before age 40, and most can't find a reason for it.

Metformin helps improve skin regeneration by increasing the growth of skin stem cells.

Understanding hair biology is key to developing better treatments for hair and scalp issues.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

Dihydrotestosterone makes arteries stiffer in female mice by reducing estrogen receptor expression.

Combining epinephrine with a steroid may help regrow hair in severe alopecia areata cases.

Early hair loss may indicate risk of insulin resistance.

Minoxidil helps treat eyebrow thinning, monilethrix, early hair loss, and shortens chemo-related hair loss.

New treatments for long-lasting erections improve outcomes but must be timely to avoid lasting damage.

Mastic gum and peppermint extracts may promote hair growth and health.

Sphinganine can reduce hair loss and improve scalp health.

Birth control pills with cyproterone acetate and drosperinone can reduce excessive hair growth in women with PCOS, but they may not be right for everyone.

People with androgenic alopecia (AGA) have a higher chance of getting metabolic syndrome.

Monilethrix is a genetic hair disorder causing fragile, beaded hair with no effective treatment.

β-blockers can cause skin problems like psoriasis and vitiligo, and doctors should tell patients about these risks.

Burn scars form abnormally due to changes in wound healing, and more research is needed to improve treatments.

Metformin improves early signs of heart disease in women with PCOS and raises apelin levels, but doesn't significantly change artery thickness.

Certain astrocytes can protect the brain and improve recovery after a stroke, and a hair loss drug might reduce cancer spread.

New treatments for skin conditions in children include a preferred drug for birthmark reduction, proactive creams for eczema and vitiligo, a safe psoriasis medication, and special tissues and socks for eczema and fungal infections.